NOD-Like Receptor Protein 3 Inflammasome Priming and Activation in Barrett’s Epithelial Cells
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
BACKGROUND & AIMS: Microbial molecular products incite intestinal inflammation by activating Toll-like receptors (TLRs) and inflammasomes of the innate immune system. This system's contribution to esophageal inflammation is not known. Gram-negative bacteria, which dominate the esophageal microbiome in reflux esophagitis, produce lipopolysaccharide (LPS), a TLR4 ligand. TLR4 signaling produces pro-interleukin (IL)1β, pro-IL18, and NOD-like receptor protein 3 (NLRP3), which prime the NLRP3 inflammasome. Subsequent NLRP3 inflammasome activation cleaves caspase-1, inducing secretion of proinflammatory cytokines and pyroptosis (inflammatory cell death). We explored LPS effects on NLRP3 inflammasome priming and activation in esophageal cells. METHODS: We exposed esophageal squamous and Barrett's epithelial cells to LPS and measured the following: (1) TLR4, pro-IL1β, pro-IL18, and NLRP3 expression; (2) caspase-1 activity; (3) tumor necrosis factor-α, IL8, IL1β, and IL18 secretion; (4) lactate dehydrogenase (LDH) release (a pyroptosis marker); and (5) mitochondrial reactive oxygen species (ROS). As inhibitors, we used acetyl-Tyr-Val-Ala-Asp-CHO for caspase-1, small interfering RNA for NLRP3, and (2-(2,2,6,6,-Tetramethylpiperidin-1-oxyl-4-ylamino)-2-oxoethyl)triphenylphosphonium chloride for mitochondrial ROS. RESULTS: Squamous and Barrett's cells expressed similar levels of TLR4, but LPS induced TLR4 signaling that increased tumor necrosis factor-α and IL8 secretion only in Barrett's cells. Barrett's cells treated with LPS showed increased expression of pro-IL18, pro-IL1β, and NLRP3, and increased mitochondrial ROS levels, caspase-1 activity, IL1β and IL18 secretion, and LDH release. Acetyl-Tyr-Val-Ala-Asp-CHO, NLRP3 small interfering RNA, and Mito-TEMPO all blocked LPS-induced IL1β and IL18 secretion and LDH release. CONCLUSIONS: In Barrett's cells, LPS both primes and activates the NLRP3 inflammasome, causing secretion of proinflammatory cytokines and pyroptosis. By triggering molecular events promoting inflammation, the esophageal microbiome might contribute to inflammation-mediated carcinogenesis in Barrett's esophagus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The LPS-PRRs/NOD-like molecules activate inflammasome to produce proinflammatory cytokines,33,34 activating TNF-α and IL-1β, two of the most eminent inflammatory cytokines.35”
From Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics (2022) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602
The human microbiome: at the interface of health and disease
Cho, I., & Blaser, M. J. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3182 · Cited by 3,449
Inflammasomes: mechanism of action, role in disease, and therapeutics
Guo, H., Callaway, J. B., & Ting, J. P.-Y. (2015) · Nature Medicine · doi:10.1038/nm.3893 · Cited by 3,340
Pyroptosis: host cell death and inflammation
Bergsbaken, T., Fink, S. L., & Cookson, B. T. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2070 · Cited by 3,183
NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?
Tschopp, J., & Schroder, K. (2010) · Nature Reviews Immunology · doi:10.1038/nri2725 · Cited by 1,850
Noncanonical Inflammasome Activation by Intracellular LPS Independent of TLR4
Kayagaki, N., Wong, M. T., Stowe, I. B., Ramani, S. R., Gonzalez, L. C., Akashi-Takamura, S., Miyake, K., Zhang, J., Lee, W. P., Muszyński, A., et al. (2013) · Science · doi:10.1126/science.1240248 · Cited by 1,545
Cytoplasmic LPS Activates Caspase-11: Implications in TLR4-Independent Endotoxic Shock
Hagar, J. A., Powell, D. A., Aachoui, Y., Ernst, R. K., & Miao, E. A. (2013) · Science · doi:10.1126/science.1240988 · Cited by 1,259
Caspase‐1‐induced pyroptotic cell death
Miao, E. A., Rajan, J. V., & Aderem, A. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01044.x · Cited by 1,137
Martinon, F., & Tschopp, J. (2004) · Cell · doi:10.1016/j.cell.2004.05.004 · Cited by 938
Inflammatory caspases and inflammasomes: master switches of inflammation
Martinon, F., & Tschopp, J. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402038 · Cited by 820
Plottel, C. S., & Blaser, M. J. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.10.003 · Cited by 743
Toll-Like Receptor-4 Promotes the Development of Colitis-Associated Colorectal Tumors
Fukata, M., Chen, A., Vamadevan, A. S., Cohen, J., Breglio, K., Krishnareddy, S., Hsu, D., Xu, R., Harpaz, N., Dannenberg, A. J., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.09.008 · Cited by 621
Spechler, S. J., & Souza, R. F. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1314704 · Cited by 495
Self-citationYang, L., Lu, X., Nossa, C. W., Francois, F., Peek, R. M., & Pei, Z. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.046 · Cited by 490
Cheng, E., Zhang, X., Huo, X., Yu, C., Zhang, Q., Wang, D. H., Spechler, S. J., & Souza, R. F. (2013) · Gut · doi:10.1136/gutjnl-2012-302250 · Cited by 348
Self-citationGastrointestinal Malignancy and the Microbiome
Abreu, M. T., & Peek, R. M. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.001 · Cited by 322
Inflammasomes in cancer: a double-edged sword
Kolb, R., Liu, G.-H., Janowski, A. M., Sutterwala, F. S., & Zhang, W. (2014) · Protein & Cell · doi:10.1007/s13238-013-0001-4 · Cited by 287
Barrett Esophagus and Risk of Esophageal Cancer: A Clinical Review
Spechler, S. J. (2013) · JAMA · doi:10.1001/jama.2013.226450 · Cited by 284
Self-citationCaspase-1: The inflammasome and beyond
Sollberger, G., Strittmatter, G. E., Garstkiewicz, M., Sand, J., & Beer, H.-D. (2014) · Innate Immunity · doi:10.1177/1753425913484374 · Cited by 275
Alfonso-Loeches, S., Ureña-Peralta, J. R., Morillo-Bargues, M. J., Oliver-De La Cruz, J., & Guerri, C. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00216 · Cited by 265 · cited 3×
“In nonesophageal cells, LPS also has been shown to cause inflammasome activation (step 2).(13,20,21) Gram-negative bacteria dominate the esophageal microbiome of patients with GERD and Barrett’s esophagus, and one earlier study found that Barrett’s epithelial cells express TLR4 that can be activated by LPS.”
BackgroundMethodHe, Y., Franchi, L., & Núñez, G. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202737 · Cited by 206
Microbial Colonization of the Upper Gastrointestinal Tract in Patients with Barrett's Esophagus
Macfarlane, S., Furrie, E., Macfarlane, G. T., & Dillon, J. F. (2007) · Clinical Infectious Diseases · doi:10.1086/518578 · Cited by 184
Inflammatory gradient in Barrett’s oesophagus: implications for disease complications
Fitzgerald, R. C., Abdalla, S., Onwuegbusi, B. A., Sirieix, P., Saeed, I. T., Burnham, W. R., & Farthing, M. J. G. (2002) · Gut · doi:10.1136/gut.51.3.316 · Cited by 184
The role of epithelial Toll-like receptor signaling in the pathogenesis of intestinal inflammation
Gribar, S. C., Anand, R. J., Sodhi, C. P., & Hackam, D. J. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0607358 · Cited by 182
Amir, I., Konikoff, F. M., Oppenheim, M., Gophna, U., & Half, E. E. (2014) · Environmental Microbiology · doi:10.1111/1462-2920.12285 · Cited by 176
Toll-Like Receptor 4 Activation in Cancer Progression and Therapy
Oblak, A., & Jerala, R. (2011) · Clinical and Developmental Immunology · doi:10.1155/2011/609579 · Cited by 175
Hilbi, H., Chen, Y., Thirumalai, K., & Zychlinsky, A. (1997) · Infection and Immunity · doi:10.1128/iai.65.12.5165-5170.1997 · Cited by 163
Inflammasomes in Intestinal Inflammation and Cancer
Chen, G. Y., & Núñez, G. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.10.002 · Cited by 150
Huo, X., Zhang, H.-Y., Zhang, X., Lynch, J., Strauch, E., Wang, J.-Y., Melton, S. D., Genta, R. M., Wang, D. H., Spechler, S., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.03.035 · Cited by 108
Self-citationCharacterization of telomerase-immortalized, non-neoplastic, human Barrett’s cell line (BAR-T)
Jaiswal, K. R., Morales, C. P., Feagins, L. A., Gandia, K., Zhang, X., Zhang, H.-Y., Hormi‐Carver, K., Shen, Y., Elder, F. F. B., Ramirez, R. D., et al. (2007) · Diseases of the Esophagus · doi:10.1111/j.1442-2050.2007.00683.x · Cited by 87
Self-citationCaspase‐11: arming the guards against bacterial infection
Stowe, I. B., Lee, B. L., & Kayagaki, N. (2015) · Immunological Reviews · doi:10.1111/imr.12292 · Cited by 79
Huo, X., Zhang, X., Yu, C., Zhang, Q., Cheng, E., Wang, D. H., Pham, T. H., Spechler, S. J., & Souza, R. F. (2013) · Gut · doi:10.1136/gutjnl-2013-305533 · Cited by 75
Self-citationVerbeek, R. E., Siersema, P. D., ten Kate, F. J. W., Fluiter, K., Souza, R. F., Vleggaar, F. P., Bus, P., & van Baal, J. W. P. M. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-013-0862-6 · Cited by 54
Self-citationZhang, H. Y., Zhang, X., Chen, X., Thomas, D., Hormi-Carver, K. K., Elder, F. F. B., Spechler, S. J., & Souza, R. F. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90262.2008 · Cited by 43
Self-citationTying the knot between cytokine and toll‐like receptor signaling in gastrointestinal tract cancers
Tye, H., & Jenkins, B. J. (2013) · Cancer Science · doi:10.1111/cas.12205 · Cited by 37
A new pharmacological effect of levornidazole: Inhibition of NLRP3 inflammasome activation
Wang, X., Wang, S., Hu, C., Chen, W., Shen, Y., Wu, X., Sun, Y., & Xu, Q. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.06.030 · Cited by 35
Current Status and Future Perspectives on the Etiology of Esophageal Adenocarcinoma
Thrift, A. P., Pandeya, N., & Whiteman, D. C. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00011 · Cited by 31
Zhang, X., Yu, C., Wilson, K., Zhang, H. Y., Melton, S. D., Huo, X., Wang, D. H., Genta, R. M., Spechler, S. J., & Souza, R. F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013093 · Cited by 29
Self-citationYu, C., Huo, X., Agoston, A. T., Zhang, X., Theiss, A. L., Cheng, E., Zhang, Q., Zaika, A., Pham, T. H., Wang, D. H., et al. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00462.2014 · Cited by 18
Self-citationQuante, M., Bhagat, G., Abrams, J. A., Marache, F., Good, P., Lee, M. D., Lee, Y., Friedman, R., Asfaha, S., Dubeykovskaya, Z., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.12.004
Cited by
Qin, S., Xiao, W., Zhou, C., Pu, Q., Deng, X., Lan, L., Liang, H., Song, X., & Wu, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01056-1 · Cited by 1,703
Pyroptosis: A new frontier in cancer
Fang, Y., Tian, S., Pan, Y., Li, W., Wang, Q., Tang, Y., Yu, T., Wu, X., Shi, Y., Ma, P., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109595 · Cited by 1,049
The role of pyroptosis in cancer: pro-cancer or pro-“host”?
Xia, X., Wang, X., Cheng, Z., Qin, W., Lei, L., Jiang, J., & Hu, J. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1883-8 · Cited by 856
Meftahi, G. H., Jangravi, Z., Sahraei, H., & Bahari, Z. (2020) · Inflammation Research · doi:10.1007/s00011-020-01372-8 · Cited by 289
Metadata
- Authors
- Nadatani, Y., Huo, X., Zhang, X., Yu, C., Cheng, E., Zhang, Q., Dunbar, K. B., Theiss, A., Pham, T. H., Wang, D. H., Watanabe, T., Fujiwara, Y., Arakawa, T., Spechler, S. J., & Souza, R. F.
- Venue
- Cellular and Molecular Gastroenterology and Hepatology
- Publisher
- Elsevier BV
- Published
- 2016-07
- Volume
- 2
- Issue
- 4
- Pages
- 439-453
- ISSN
- 2352-345X
- Cited by
- 69
- References
- 41
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.